AU8058194A - A pharmaceutical composition for the treatment of coronary thrombosis - Google Patents

A pharmaceutical composition for the treatment of coronary thrombosis

Info

Publication number
AU8058194A
AU8058194A AU80581/94A AU8058194A AU8058194A AU 8058194 A AU8058194 A AU 8058194A AU 80581/94 A AU80581/94 A AU 80581/94A AU 8058194 A AU8058194 A AU 8058194A AU 8058194 A AU8058194 A AU 8058194A
Authority
AU
Australia
Prior art keywords
treatment
pharmaceutical composition
coronary thrombosis
thrombosis
coronary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80581/94A
Other languages
English (en)
Inventor
Claus Bregengaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU8058194A publication Critical patent/AU8058194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU80581/94A 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis Abandoned AU8058194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (enrdf_load_stackoverflow) 1993-11-05 1993-11-05
DK1256/93 1993-11-05
PCT/DK1994/000414 WO1995012407A1 (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis

Publications (1)

Publication Number Publication Date
AU8058194A true AU8058194A (en) 1995-05-23

Family

ID=8102801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80581/94A Abandoned AU8058194A (en) 1993-11-05 1994-11-03 A pharmaceutical composition for the treatment of coronary thrombosis

Country Status (5)

Country Link
AU (1) AU8058194A (enrdf_load_stackoverflow)
DK (1) DK125693D0 (enrdf_load_stackoverflow)
IL (1) IL111501A0 (enrdf_load_stackoverflow)
WO (1) WO1995012407A1 (enrdf_load_stackoverflow)
ZA (1) ZA948721B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
CN106890320A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种用于预防或治疗急性及慢性血栓的方法
CN108778320A (zh) * 2015-12-18 2018-11-09 泰伦基国际有限公司 一种预防和治疗心血管病的新方法
ES2968254T3 (es) 2015-12-18 2024-05-08 Talengen Int Ltd Plasminógeno para su uso en la prevención o el tratamiento de la trombosis aguda y la trombosis crónica
TWI642442B (zh) 2016-12-15 2018-12-01 深圳瑞健生命科學硏究院有限公司 纖溶酶原在製備降低胰高血糖素分泌的藥物上的用途
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
WO2018108161A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法和药物
US20190328850A1 (en) 2016-12-15 2019-10-31 Talengen International Limited Method for preventing and treating lipid metabolism disorders and related diseases thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE

Also Published As

Publication number Publication date
ZA948721B (en) 1995-05-08
DK125693D0 (enrdf_load_stackoverflow) 1993-11-05
WO1995012407A1 (en) 1995-05-11
IL111501A0 (en) 1995-01-24

Similar Documents

Publication Publication Date Title
AU2103295A (en) Methods for the treatment of thrombosis
AU6623894A (en) Therapeutic compounds
HU9402974D0 (en) Pharmaceutical composition
AU7961094A (en) Picosulphate dosage form
AU6253094A (en) Methods for the treatment of osteoporosis
AU6092794A (en) Oxime-substituted therapeutic compounds
ZA945930B (en) Pharmaceutical composition
HUT69779A (en) Cyklodextringlycosyltransferasen for production of gamma-cyclodextrin
AU8058194A (en) A pharmaceutical composition for the treatment of coronary thrombosis
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU5518694A (en) Treatment of a group of related disorders
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (en) Pharmaceutical composition
ZA945752B (en) Pharmaceutical composition
AU6973294A (en) Method for treatment of a piece
HK1002139A1 (en) A pharmaceutical composition having anti-decrepit action and a process for preparation thereof
GB9318880D0 (en) Pharmaceutical composition
PL313116A1 (en) Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs
AU5813694A (en) Treatment of plant material
AU7141194A (en) Process for the manufacture of phenoxyphenoxyalkyl derivatives
AU3528593A (en) Pharmaceutical composition
SG47980A1 (en) Pharmaceutical compositions
AUPM303393A0 (en) Pharmaceutical composition